Celgene

Celgene Corporation reports record revenue and operating profits

Published in Physician Law Weekly, August 23rd, 2006

Celgene Corporation (CELG) announced adjusted net income of $42.6 million, or adjusted earnings per diluted share of $0.11 for the quarter ended June 30, 2006.

On a reported basis under U.S. Generally Accepted Accounting Principles (GAAP), Celgene reported net income of $9.6 million, or diluted earnings per share of $0.03, including share-based employee compensation expense, compared to net income in the prior year period of $10.8 million. Total revenue was a record $197.2 million for the quarter ended June 30, 2006, an increase of 35.4% (56.8% excluding a one-time milestone payment) over the same period in 2005 driven by strong Revlimid net sales of $63.0 million, and...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Physician Law Weekly

Source: Physician Law Weekly (2006-08-23)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry